In this issue:
Femtosecond laser in cataract surgery
Verteporfin PDT adds no benefit to ranibizumab monotherapy... ...and does not reduce ranibizumab retreatment rates ...but low-dose transpupillary therapy does
IOP elevations with anti-VEGF therapy... ...preventable wi
Please login below to download this issue (PDF)